• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Suppressor of IKBKE 1 (SIKE1)

ACP10444

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10444 Target NameSIKE1
Target SynonymsSIKE1; SIKE; Suppressor of IKBKE 1; Suppressor of IKK-epsilonFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-207
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BRV8
Background Information
  • Uniprot Id

    Q9BRV8

  • Target Species

    Human

  • Target Name

    SIKE1

  • Target Full Name

    Suppressor of IKBKE 1

  • Target Function

    Physiological suppressor of IKK-epsilon and TBK1 that plays an inhibitory role in virus- and TLR3-triggered IRF3. Inhibits TLR3-mediated activation of interferon-stimulated response elements (ISRE) and the IFN-beta promoter. May act by disrupting the interactions of IKBKE or TBK1 with TICAM1/TRIF, IRF3 and DDX58/RIG-I. Does not inhibit NF-kappa-B activation pathways.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    SIKE family

  • Target Tissue Specificity

    Widely expressed. Expressed in brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung and leukocytes. Present in all cell lines tested (at protein level).

  • Target Synonyms

    SIKE1; SIKE; Suppressor of IKBKE 1; Suppressor of IKK-epsilon

Inquire Recombinant Human Suppressor of IKBKE 1 (SIKE1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification